TScan Therapeutics, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
TCRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
880 Winter Street, Waltham, MA

Insiders trading volume in the past year

TScan Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Baker Bros. Advisors Lp Director $308M Jun 12, 2024
Lynx1 Capital Management LP 10%+ Owner $45.5M +$30.4M +201% Dec 26, 2024
EcoR1 Capital, LLC 10%+ Owner $24.8M May 26, 2023
H. Westphal 10%+ Owner $10.9M Jul 20, 2021
David P. Southwell Chief Executive Officer, Director $852K Feb 2, 2023
Barbara Klencke Director $644K +$82.6K +14.7% Sep 23, 2024
Timothy Barberich Director $498K Dec 18, 2023
Brian M. Silver Chief Financial Officer $163K Jun 13, 2023
Zoran Zdraveski Chief Legal and Strategy Officer $27.3K -$952K -97.2% Aug 23, 2024
William Desmarais Chief Business Officer $12.4K Jul 25, 2022
Jason Amello Chief Financial Officer Jan 3, 2025
Stephen R. Biggar Director Jul 15, 2021
Chrystal Louis Chief Medical Officer Jan 3, 2025
Garry A. Nicholson Director Jun 12, 2024
Katina Dorton Director Jun 12, 2024
Gavin MacBeath Chief Executive Officer, Director Jan 12, 2024
Keith Woods Director Jun 12, 2024
Leiden Dworak Vice President, Finance Jan 12, 2024
Debora Barton Chief Medical Officer Jun 13, 2023
Gabriela Gruia Director Jun 12, 2024
Ittai Harel Director Jun 1, 2022

Recent Insider Transactions by Companies or Individuals for TScan Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.